Sangamo beefs up management team with two new appointments

• Sangamo BioSciences (NASDAQ:SGMO) appoints Edward Connor, M.D. as SVP and chief medical officer effective immediately. He joins the firm from Ultragenyx Pharmaceutical (RARE -1.4%).
• VP of corporate development Curt Herberts has been promoted to the newly created role of SVP and chief business officer. He joined the company in October 2010.